skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Abstract

The present invention relates to variants of GH61 polypeptides having cellulolytic enhancing activity, wherein the variants comprise a substitution at one or more positions corresponding to positions 90, 131, 134, and 141 of the full-length polypeptide of SEQ ID NO: 2, and have cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

Inventors:
;
Issue Date:
Research Org.:
Novozymes, Inc., Davis, CA(United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1568143
Patent Number(s):
10,246,691
Application Number:
13/876,759
Assignee:
Novozymes, Inc. (Davis, CA)
DOE Contract Number:  
FC36-08GO18080
Resource Type:
Patent
Resource Relation:
Patent File Date: 09/29/2011
Country of Publication:
United States
Language:
English

Citation Formats

Sweeney, Matthew, and Wogulis, Mark. Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same. United States: N. p., 2019. Web.
Sweeney, Matthew, & Wogulis, Mark. Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same. United States.
Sweeney, Matthew, and Wogulis, Mark. Tue . "Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same". United States. https://www.osti.gov/servlets/purl/1568143.
@article{osti_1568143,
title = {Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same},
author = {Sweeney, Matthew and Wogulis, Mark},
abstractNote = {The present invention relates to variants of GH61 polypeptides having cellulolytic enhancing activity, wherein the variants comprise a substitution at one or more positions corresponding to positions 90, 131, 134, and 141 of the full-length polypeptide of SEQ ID NO: 2, and have cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {4}
}

Patent:

Save / Share: